Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dry Eye
Conditions
Dry Eye, Meibomian Gland Dysfunction
Trial Timeline
Apr 28, 2021 → Sep 23, 2024
NCT ID
NCT04795752About Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion
Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion is a pre-clinical stage product being developed by Sight Sciences for Dry Eye. The current trial status is completed. This product is registered under clinical trial identifier NCT04795752. Target conditions include Dry Eye, Meibomian Gland Dysfunction.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04795752 | Pre-clinical | Completed |
Competing Products
20 competing products in Dry Eye